Pulse Biosciences director granted 30,000 stock options
Pulse Biosciences director Manmeet Singh Soni received a grant of stock options, not a share purchase.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Pulse Biosciences director Manmeet Singh Soni received a grant of stock options, not a share purchase. The award covers 30,000 options to buy Common Stock at an exercise price of $26.89 per share, expiring on June 11, 2036. These options vest in equal monthly installments over one year, starting on July 11, 2026, contingent on continued service, leaving Soni with 30,000 derivative securities after the grant.
Insider Trade Summary
Grant/Award: 30,000 shares
Grant/Award
1 txn
Insider
Soni Manmeet Singh
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 30,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 30,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on July 11, 2026.
Key Figures
Options granted: 30,000 options
Exercise price: $26.89 per share
Underlying shares: 30,000 shares
+3 more
6 metrics
Options granted
30,000 options
Grant of Stock Option (right to buy) on June 11, 2026
Exercise price
$26.89 per share
Exercise price for Common Stock under the option grant
Underlying shares
30,000 shares
Common Stock underlying the granted options
Expiration date
June 11, 2036
Option term end for the granted stock options
Post-grant derivative holdings
30,000 options
Total derivative securities following the transaction
Vesting start date
July 11, 2026
First monthly vesting installment for the option grant
Key Terms
Stock Option (right to buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
exercise price financial
"conversion_or_exercise_price: 26.8900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"shares subject to the option will vest in equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Pulse Biosciences (PLSE) report for Manmeet Singh Soni?
Pulse Biosciences reported that director Manmeet Singh Soni received a grant of 30,000 stock options. These options are a compensation award, not an open-market share purchase or sale, and give the right to buy Common Stock at a fixed exercise price.
How many stock options were granted to the Pulse Biosciences (PLSE) director?
The director received 30,000 stock options. Each option represents the right to buy one share of Pulse Biosciences Common Stock, subject to vesting conditions and an exercise price, providing potential future equity exposure rather than immediate share ownership.
What is the exercise price of the new Pulse Biosciences (PLSE) stock options?
The stock options were granted with an exercise price of $26.89 per share. This means the director can buy Pulse Biosciences Common Stock at $26.89 once the options vest, regardless of the market price at the time of exercise.
When do the new Pulse Biosciences (PLSE) options vest for Manmeet Singh Soni?
The options vest in equal monthly installments over one year, beginning July 11, 2026. Vesting is contingent on the director’s continued service, gradually making more options exercisable each month until the full 30,000 have vested.
When do the granted Pulse Biosciences (PLSE) stock options expire?
The stock options expire on June 11, 2036. After that expiration date, any unexercised options will lapse and can no longer be used to purchase Pulse Biosciences Common Stock, even if they had previously vested.
How many derivative securities does the Pulse Biosciences (PLSE) director hold after this grant?
Following this grant, the director holds 30,000 derivative securities in the form of stock options. This figure reflects the newly awarded options and shows the size of the director’s option-based equity position after the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates